Mumbai, January 31, 2025 – Rossari Biotech Limited (NSE: ROSSARI, BSE: 543213) announced a favorable ruling in its GST appeal case before the Additional Commissioner, Central GST & Central Excise, Appeals Commissionerate, Surat.
Key Highlights:
- Regulatory Filing: The company filed an appeal against an earlier order received from the Assistant Commissioner, Division-VII, CGST & C. Excise, Daman Commissionerate.
- Favorable Verdict: On January 29, 2025, the Additional Commissioner ruled in favor of Rossari Biotech, allowing the company's appeal.
- Official Confirmation: Rossari Biotech received the official order on January 30, 2025.
- Compliance with SEBI Regulations: The company disclosed the update under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.